Global Leading Market Research Publisher QYResearch announces the release of its latest report “Animal Gene Chip – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032”. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global animal gene chip market, including market size, share, demand, industry development status, and forecasts for the next few years.
The global market for animal gene chip was estimated to be worth US61.4millionin2025andisprojectedtoreachUS61.4millionin2025andisprojectedtoreachUS 84.9 million, growing at a CAGR of 4.8% from 2026 to 2032. This sustained growth is driven by increasing adoption of genomic selection in livestock breeding programs (dairy cattle, beef cattle, pigs, poultry), growing demand for genetic disease screening in companion animals (horses, dogs, cats), expanding applications in veterinary diagnostic and pharmaceutical development, and declining costs of DNA microarray technology enabling broader accessibility.
Animal gene chip (also called animal DNA microarray) is a type of biochip specifically designed to analyze genetic information in animals. It allows simultaneous detection and analysis of thousands of genes or genetic markers from animal DNA or RNA. These genomic analysis tools enable breeders, veterinarians, and researchers to perform genome-wide association studies (GWAS), estimate genomic breeding values (GEBV), screen for genetic disorders, evaluate parentage, assess biodiversity, and predict desirable production traits (milk yield, growth rate, meat quality, disease resistance). By providing comprehensive SNP (single nucleotide polymorphism) genotype data from a single assay, animal gene chips have revolutionized livestock breeding and veterinary genetics, replacing less efficient single-marker tests and traditional pedigree-based selection methods.
For comprehensive market segmentation, species-specific comparisons, and application intelligence, industry stakeholders can access the complete dataset.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/6092917/animal-gene-chip
Market Segmentation by Species and Application
The animal gene chip market is segmented as below to reflect distinct species focus and end-use sectors:
Selected Key Players (Partial List):
Thermo Fisher Scientific, Agilent, Illumina, National Dairy Technology Innovation Center
Segment by Species
- Cattle Gene Chip – For dairy and beef cattle genomic selection, disease resistance screening, parentage verification
- Horse Gene Chip – For equine performance traits (racing, dressage, jumping), coat color genetics, inherited disease screening
- Other – Gene chips for pigs, sheep/goats, chickens, dogs, cats, aquaculture species
Segment by Application
- Medical Diagnosis – Veterinary detection of genetic disorders, inherited disease risk assessment
- Drug Development – Animal model genotyping for pharmaceutical research, toxicogenomics
- Animal Breeding – Genomic selection, parentage verification, conservation genetics
- Other – Forensic identification (traceability), research, biodiversity monitoring
Technical Deep Dive: Microarray Design and Genomic Selection Applications
A critical technical consideration in selecting an animal gene chip is the SNP marker content and density appropriate for the application. Cattle gene chips represent the largest segment (approximately 55-60% of market value), with commercially available chips ranging from low-density (10,000-50,000 SNPs) for parentage verification and traceability, to medium-density (50,000-100,000 SNPs) for routine genomic selection, to high-density (700,000+ SNPs) for research and advanced breeding applications. Illumina’s BovineSNP50 BeadChip (50,000+ SNPs) remains an industry standard for dairy cattle genomic selection, with over 1 million animals genotyped globally. A 2025 industry survey reported that 78% of large-scale U.S. and European dairy operations (>500 cows) incorporate genomic selection using commercial gene chips, up from 45% in 2018.
Genomic selection—predicting breeding values using genome-wide marker information—has dramatically accelerated genetic gain in livestock. For dairy cattle, the use of animal breeding gene chips has reduced the generation interval from approximately 5-6 years (traditional progeny testing) to 1.5-2 years (genomic prediction of young bulls), doubling the rate of genetic improvement. A 2026 economic analysis estimated that the U.S. dairy industry gains approximately $200-250 million annually through increased milk production and health traits from genomic selection enabled by animal DNA microarray technology.
The horse gene chip segment (approximately 15-20% of market value) serves both performance horse breeding and inherited disease screening. Equine genetic tests have identified markers for performance traits (DQ1 for racing distance preference, MSTN for sprinting ability), coat colors (cream dilution, silver dapple), and inherited disorders (hyperkalemic periodic paralysis, hereditary equine regional dermal asthenia, polysaccharide storage myopathy). The EquineSNP50 BeadChip (Illumina) is widely used, and a 2025 industry report indicated that approximately 35% of thoroughbred foals in North America are genotyped at birth.
A distinctive technical challenge for animal genomics chips is the species-specific SNP discovery. Most commercial chips have been developed for major livestock (cattle, pigs, chickens) and horses, with limited coverage for minor species (goats, sheep, farmed fish, camelids, exotic species). Research and specialty breeding applications for minor species often require custom-designed chips, which are more expensive and have lower adoption. Agilent and Thermo Fisher Scientific both offer custom microarray design services with minimum order quantities of 50-500 chips.
Recent Market and Technological Developments
The animal gene chip market has experienced significant developments in 2025-2026. In October 2025, Illumina launched the BovineSNP150K BeadChip, a high-density chip (150,000 SNPs with enhanced coverage of functional regions) designed to support genomic selection for traits previously difficult to predict, including feed efficiency, methane emissions, and calving ease. The chip includes markers for polled (hornless) genetics and disease resistance (bovine leukocyte adhesion deficiency, complex vertebral malformation). Early adopter data (Holstein Association USA) showed a 12-15% increase in genomic prediction accuracy for low-heritability traits compared to the original 50K chip.
In November 2025, the USDA’s Animal Genomics and Improvement Laboratory launched the “NextGen Genotyping” initiative, providing subsidized access to medium-density animal gene chips for smaller dairy and beef operations. The 5-year program, funded at $25 million, aims to expand genomic selection beyond large operations and is expected to add approximately 50,000-75,000 genotypes annually to the U.S. genetic evaluation database.
In January 2026, Thermo Fisher Scientific introduced the Axiom Porcine Genotyping Array 100K, a 100,000-SNP chip for pig genetics covering economically important traits including growth rate (average daily gain), feed conversion ratio, backfat thickness, and meat quality (intramuscular fat, pH, color). The chip includes markers for stress susceptibility (halothane gene, Ryanodine receptor 1) and disease resistance (porcine reproductive and respiratory syndrome). Adoption is expected in large-scale pig breeding operations in China (the world’s largest pork producer), Europe, and North America.
Regional market dynamics reveal that North America accounts for approximately 45% of global animal gene chip demand, driven by advanced dairy and beef genomic selection programs, large-scale horse breeding (thoroughbred, quarter horse), and research funding. Europe represents approximately 30%, with strong adoption in dairy (Netherlands, Germany, Denmark, France) and pig breeding. Asia-Pacific is the fastest-growing region (CAGR 6-7%), led by China (growing dairy and pig industries, government-supported animal genomics infrastructure) and Australia (beef cattle and sheep genomic selection). The National Dairy Technology Innovation Center (Beijing) has developed a custom cattle chip for Chinese indigenous breeds (Holstein, Jersey, Simmental, local yellow cattle) optimized for traits relevant to Chinese dairy production systems.
Industry Sub-segment Divergence: Commercial Breeding vs. Research Applications
The animal gene chip market divides meaningfully between commercial breeding programs and research applications. Commercial breeding applications (approximately 70-75% of demand) prioritize cost-per-sample (mass genotyping), rapid turnaround (weeks, not months), and chips with established genomic prediction equations specific to the breed and production system. Commercial users process large volumes (hundreds to thousands annually) and often have contracts with service laboratories rather than running chips onsite. Dairy genetic evaluation companies (e.g., CDCB in US, Interbull internationally) periodically update genomic prediction equations as training populations expand.
Research applications (approximately 25-30% of demand) prioritize marker density and coverage depth for GWAS, fine mapping, functional genomics, and evolutionary studies rather than per-sample cost. Researchers often use high-density chips (700K+ SNPs) or custom targeted sequencing approaches. A distinctive exclusive observation: the conservation genetics segment is growing at 8-10% annually, as zoos, wildlife agencies, and biodiversity researchers apply animal gene chips to assess genetic diversity, manage captive breeding populations, and identify unique genetic lineages for endangered species (giant panda, black rhino, California condor, Ethiopian wolf). Conservation applications require custom chips for non-model species, which are more expensive and have limited commercial viability, but represent an important niche for Thermo Fisher Scientific and Agilent’s custom microarray services.
Future Outlook and Strategic Recommendations
As the animal gene chip market evolves toward 2032, three strategic directions emerge: (1) migration from fixed-content microarrays to genotyping-by-sequencing (GBS) and low-pass whole-genome sequencing (lpWGS) for research applications requiring higher marker density, though cost-benefit analysis currently favors microarrays for routine commercial breeding; (2) integration of chip-based genotyping with imputation to higher density or sequence level, enabling cost-effective genotyping of high volumes with subsequent imputation to full sequence; (3) expansion of chips for emerging aquaculture species (Atlantic salmon, tilapia, shrimp) and companion animals (dogs and cats for personalized veterinary medicine). For livestock breeders, selecting an animal gene chip with established genomic prediction equations for target breeds (dairy Holstein, beef Angus, Duroc pigs), appropriate marker density (low to medium for routine selection, high for research), and competitive per-sample pricing is essential. For research institutions, prioritizing custom chip flexibility, vendor-provided analysis tools, and compatibility with existing genotyping infrastructure offers best value. For animal genomics manufacturers, differentiation will increasingly come from species-specific chip content informed by large training populations, integration with cloud-based genomic prediction platforms, and partnerships with breed associations and genetic evaluation centers. By 2030, it is anticipated that high-density chips (150K+) will represent over 40% of commercial animal DNA microarray sales, as the incremental cost of higher density decreases and enhanced prediction accuracy for low-heritability traits becomes economically justifiable.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
